Blood culture isolates in hemodialysis vascular catheter-related bacteremia

American Journal of the Medical Sciences

Volumn 336, Issue 4, 2008, Pages 297-302

  Alexandraki, Irene ^a   Sullivan, Robert ^a   Zaiden, Robert ^a   Bailey, Christina ^a   McCarter, Yvette ^a   Khan, Akram ^a   Offutt, Julie K ^b   Bhatt, Udayan Y ^c   Plott, Darcy ^c   Nahman Jr , N Stanley ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Bacteremia; Blood cultures; Epidemiology; Hemodialysis; Vascular catheters

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; GENTAMICIN; LEVOFLOXACIN; VANCOMYCIN;

ACINETOBACTER; ADULT; AEROMONAS; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACILLUS; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD VESSEL CATHETERIZATION; CANDIDA; CATHETER INFECTION; CITROBACTER; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; DRUG UTILIZATION; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KLEBSIELLA; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS; MORGANELLA; OUTCOME ASSESSMENT; PEPTOSTREPTOCOCCUS; PROPIONIBACTERIUM; PROTEUS; PSEUDOMONAS; SERRATIA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PYOGENES;

EID: 56049090809     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181637432     Document Type: Article

References (11)

1. NKF-K/DOQI. Clinical practice guidelines for vascular access: update 2006. III. Prevention of complications: infection. National kidney foundation. Am J Kidney Dis 2006;48 (Suppl 1):S248-S273.
2. Quarello F, Forneris G, Borca M, et al. Do central venous catheters have advantages over arteriovenous fistulas or grafts? J Nephrol 2006;19:265-79.
3. US Renal Data System. (The National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, MD). USRDS 1996 Annual Data Report. 2007 Available at: http://www.usrds.org/2007/pdf/03_pt_char_ 07.pdf, accessed 10/07/07.
4. National Kidney Foundation. DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 1997;30(4 Suppl 3):S150-S191.
5. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for disease control and prevention. MMWR Recomm Rep 2002;51(RR-10):1-29.
6. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-72.
7. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 2004;44:779-91.
8. Mokrzycki MH, Zhang M, Cohen H, et al. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 2006;21:1024-31.
9. Kara IH, Yilmaz ME, Sit D, et al. Bacteremia caused by Stenotrophomonas maltophilia in a dialysis patient with a long-term central venous catheter. Infect Control Hosp Epidemiol 2006;27:535-6.
10. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990;69:296-306.
11. Lok CE, Stanley KE, Hux JE, et al. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003;14:169-79.